04 June 2024 Merck’s Innovative Oncology Pipeline of DNA Damage Response Inhibitors and Antibody-Drug Conjugates Poised to Advance Cancer Treatment 0 minute read Pharma/Biotech By Cate Swannell Previous Post Next Post